You are here

  • Home
  • Archive
  • Volume 66, Issue Suppl 2
  • PTH-099 A novel approach to the implementation of biosimilar infliximab ct-p13 for the treatment of ibd utilising therapeutic drug monitoring: the edinburgh experience

Article metrics

Article menu
Download PDFPDF
Inflammatory Bowel Disease
PTH-099 A novel approach to the implementation of biosimilar infliximab ct-p13 for the treatment of ibd utilising therapeutic drug monitoring: the edinburgh experience

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20174302
Jul 20173403
Aug 20171700
Sep 20173401
Oct 20172200
Nov 20172403
Dec 2017400
Jan 20181400
Feb 20184800
Mar 20182402
Apr 20182204
May 20181100
Jun 20182001
Jul 20183401
Aug 20182101
Sep 2018800
Oct 2018600
Nov 20181001
Dec 20181000
Jan 2019400
Feb 2019200
Apr 2019300
May 2019600
Jun 20191601
Jul 20191300
Aug 20191001
Sep 2019200
Oct 2019800
Nov 2019600
Dec 2019600
Jan 2020600
Feb 2020800
Mar 2020200
Apr 2020600
Jul 20201000
Aug 2020300
Sep 20209401
Oct 20201000
Nov 2020600
Dec 2020600
Jan 2021200
Feb 20211000
Mar 2021800
Apr 2021401
May 2021500
Aug 2021001
Nov 20211000
Jan 2022800
Feb 2022800
Mar 20221200
Apr 20221400
May 20222200
Jun 2022800
Jul 2022400
Aug 2022501
Sep 2022400
Oct 2022900
Nov 2022600
Dec 20221200
Jan 20231400
Feb 20232600
Mar 20231000
May 20232001
Jul 2023300
Aug 2023100
Sep 2023600
Oct 2023400
Nov 2023601
Dec 2023600
Jan 2024400
Feb 2024600
Mar 2024400
Total894027